期刊文献+

盐酸小檗碱对心脏移植受者环孢素A血浓度的影响 被引量:6

Effect of Berberin Hydrochloride on Blood Concentration of Cyclosporine A in Cardiac Transplanted Recipients
下载PDF
导出
摘要 目的观察联合应用盐酸小檗碱(黄连素,berberin hydrochloride,Ber)对心脏移植受者环孢素A(cyclosporineA,CsA)血浓度的影响。方法观察22例服用CsA心脏移植受者联合服用Ber后CsA全血浓度,肝、肾功能和血脂变化。结果合用Ber后CsA全血稳态C0和C2浓度与合用前比较明显增加(P〈0.01),平均浓度分别增加26%和18%;21例服用CsA剂量减少25~100mg/d,Ber与CsA合用对受者的肝、肾功能及血脂无明显影响(P〉0.05)。结论合用Ber能升高心脏移植受者CsA血浓度,减少CsA服用剂量,节省费用,且无明显不良反应。 Objective To observe the clinic effect of combined use of berberin hydrochloride (Ber) with cyclosporine A (CsA) on the blood concentration of CsA in heart transplanted recipients. Methods The blood con- centration of CsA, liver-renal function and blood lipids in 22 heart transplanted recipients, who received Ber-CsA combined therapy, were measured. Results The whole blood steady state concentration of CsA, Co and C2, in recipients after being treated with Ber-CsA significantly increased than those before applying Ber-CsA ( P 〈 0. 01 ), with the mean increment of 26% and 18% respectively; the dosage of CsA used decreased in 21 patients by 25-100 mg/d;and the Ber-CsA showed no significant effect on liver-renal function or blood lipids (P 〉 0. 05 ). Conclusion Combined use of CsA with Ber could markedly increase the blood concentration of CsA in heart transplanted recipients and reduce the dosage of CsA required, save the fee for medical service, and shows no obvious adverse reaction.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2008年第8期702-704,共3页 Chinese Journal of Integrated Traditional and Western Medicine
关键词 盐酸小檗碱(黄连素) 心脏移植 环孢素A 血药浓度 berberin hydrochloride heart transplantation cyclosporine A drug concentration in blood
  • 相关文献

参考文献5

二级参考文献15

  • 1许林海,倪科伟,钱文伟,倪旭鸣,严志焜.心脏移植12例随访观察[J].中华医学杂志,2004,84(11):885-887. 被引量:4
  • 2黄雪珊,陈道中,陈良万,翁钦永,邱罕凡,吴锡阶,廖崇先.心脏移植围术期处理经验[J].中国循环杂志,2004,19(3):222-224. 被引量:19
  • 3山田阳城,周德文.黄连的药理和药效[J].国外医药(植物药分册),1993,8(2):70-73. 被引量:8
  • 4久保道德,周德文.葛根及其方剂的药理[J].国外医药(植物药分册),1993,8(4):169-171. 被引量:1
  • 5[1]Akhlaghi F, Jackson CH, Parameshwar J, Sharples LD, Trull AK. Risk factors for the development and progression of dyslipidemia after heart transplantation. Transplantation, 2002, 73 (8): 1 258-264
  • 6[2]Stapleton DD, Mehra MR, Dumas D, Smart FW, Milani RV, Lavie CJ, et al. Lipid-lowering therapy and long-term survival in heart transplantation. Am J Cardiol, 1997, 80 (6): 802-805
  • 7Kirklin JK. The donor heart. In: Kirklin JK, ed. Heart transplantation. Birmingham: Churchill Livngstone, 2002. 293-338.
  • 8Zeier M, Dohler B, Opelz G, et al. The effect of donor gender on graft survival. J Am Soc Nephrol, 2002, 13: 2570-2576.
  • 9De Santo LS, Marra C, De Feo M, et al. The impact of gender on heart transplantation outcomes: a single center experience. Ital Heart J, 2002, 3: 419-423.
  • 10Prendergast TW, Furukawa S, Beyer AJ 3rd, et al. The role of gender in heart transplantation. Ann Thorac Surg, 1998, 65: 88-94.

共引文献53

同被引文献59

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部